-

 

Asthma and PFAS Exposure: Emerging Evidence, Mechanistic Insights, and Policy Implications for Public Health

Abstract

Per- and polyfluoroalkyl substances (PFAS) represent a vast group of synthetic fluorinated compounds used globally in industrial and consumer products due to their resistance to heat, water, and degradation. However, their persistence in the environment and bioaccumulative properties have raised major health concerns. Emerging research links PFAS exposure to respiratory illnesses, particularly asthma, through immune modulation, inflammation, and endocrine disruption. This paper explores the scientific evidence connecting PFAS and asthma, emphasizing mechanisms of toxicity, exposure pathways in African contexts, and the policy implications for public health regulation, prevention, and environmental justice. It concludes with actionable recommendations for Kenya and similar settings aiming to strengthen national chemical safety frameworks and asthma management strategies.

1. Introduction

Asthma is a chronic, multifactorial inflammatory disease of the airways affecting approximately 339 million people globally, according to the World Health Organization (WHO). It is one of the most common non-communicable diseases (NCDs) in Africa, where its prevalence has been rising due to urbanization, air pollution, and climate-related stressors. At the same time, exposure to persistent organic pollutants (POPs), notably PFAS, is expanding due to industrialization, the spread of imported consumer goods, and weak waste management systems.

PFAS exposure represents a “silent threat” to respiratory health. These compounds are found in non-stick cookware, food packaging, firefighting foams, water-resistant textiles, pesticides, and personal care products. In Africa, including Kenya, PFAS contamination has been detected in surface water, sediments, and fish, particularly in Lake Victoria, Nairobi River Basin, and industrial zones. Understanding PFAS’s contribution to asthma provides a critical framework for preventive health policy, environmental regulation, and sustainable industrial practices.

2. PFAS: Characteristics, Sources, and Environmental Pathways

PFAS are known as “forever chemicals” due to their strong carbon-fluorine bonds, making them resistant to environmental degradation. Common compounds include perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), and newer alternatives such as GenX.

Key exposure pathways include:

  • Inhalation: Indoor dust from PFAS-treated fabrics, carpets, and furnishings; outdoor emissions from waste burning and manufacturing.

  • Ingestion: Contaminated drinking water, especially near industrial discharge points or dumpsites; consumption of PFAS-laden fish and agricultural produce.

  • Dermal absorption: From personal care and cosmetic products containing fluorinated surfactants.

  • Maternal-fetal transfer: PFAS cross the placenta and are found in cord blood and breast milk, exposing infants during critical immune and lung development stages.

In Kenya and sub-Saharan Africa, informal recycling, open burning of plastics, and improper waste disposal are major contributors to PFAS release into soil, air, and water. Contamination hotspots often coincide with urban slums and industrial zones, intensifying exposure among vulnerable populations.

3. Mechanistic Links Between PFAS and Asthma

The association between PFAS exposure and asthma is biologically plausible and supported by toxicological evidence demonstrating immune, inflammatory, and endocrine disruption.

a. Immune Dysregulation
PFAS alter immune responses by affecting T-helper cell differentiation and cytokine production. The shift toward a Th2-dominant immune profile favors allergic inflammation and airway hyperresponsiveness. PFAS exposure also reduces antibody response to vaccines, demonstrating its immunosuppressive potential.

b. Airway Inflammation and Remodeling
PFAS can activate peroxisome proliferator-activated receptors (PPAR-α and PPAR-γ) in lung tissues, leading to lipid metabolism disruption and chronic inflammation. This can result in epithelial thickening, mucus hypersecretion, and airway remodeling—hallmarks of chronic asthma.

c. Oxidative Stress
Chronic exposure leads to oxidative injury in bronchial epithelial cells through reactive oxygen species (ROS) accumulation. This amplifies local inflammation and sensitizes the airway to environmental triggers like dust and smoke.

d. Endocrine and Hormonal Interference
PFAS disrupt glucocorticoid receptor signaling, potentially diminishing responsiveness to inhaled corticosteroids, the mainstay of asthma therapy. This mechanism may partly explain steroid-resistant asthma observed in chronically exposed populations.

4. Epidemiological Evidence

  • Children: Several cohort studies in Europe and North America have shown associations between elevated PFAS serum levels and increased risk of asthma and allergic rhinitis. For example, the C8 Health Project in the U.S. linked PFOS and PFOA exposure to higher asthma prevalence in children.

  • Adults: Occupational exposure studies among chemical workers and firefighters revealed impaired lung function and higher incidence of respiratory symptoms.

  • Prenatal Exposure: Longitudinal studies demonstrate that maternal PFAS levels during pregnancy are associated with wheezing and asthma-like symptoms in early childhood.

Although few studies exist in African contexts, biomonitoring data suggest rising PFAS levels in human tissues and the environment, warranting urgent epidemiological investigations across East Africa.

5. Public Health Implications

The PFAS–asthma nexus presents a multidimensional public health concern:

  • Increased disease burden: Asthma exacerbations lead to reduced quality of life, absenteeism, and higher healthcare costs.

  • Vulnerable populations: Children, women, and industrial workers face disproportionate risks due to physiological and social vulnerabilities.

  • Healthcare capacity: Most African health systems focus on infectious diseases, leaving chronic diseases like asthma underdiagnosed and undertreated.

  • Environmental injustice: Low-income communities often reside near contaminated water sources or waste sites, compounding exposure and limiting access to healthcare.

6. Policy and Regulatory Gaps

Despite global recognition of PFAS hazards, regulatory control in Africa remains minimal:

  • Lack of chemical registration and monitoring: Few countries, including Kenya, have PFAS-specific monitoring programs under environmental agencies like NEMA or the Pest Control Products Board (PCPB).

  • Limited integration of health and environment sectors: PFAS exposure is rarely considered in asthma prevention or management policies.

  • Global policy misalignment: While the Stockholm Convention on POPs includes PFOS and PFOA, enforcement and substitution efforts lag behind in developing regions.

  • Information deficits: Public awareness of PFAS risks remains low among healthcare workers and consumers.

7. Policy Recommendations

  1. National PFAS Regulation:
    Establish binding standards for PFAS levels in air, water, food, and consumer products, harmonized with WHO and UNEP guidelines.

  2. Integrated Surveillance:
    Develop joint NEMA–Ministry of Health biomonitoring programs to track PFAS exposure and respiratory outcomes across regions.

  3. Public Awareness Campaigns:
    Educate communities on PFAS exposure sources and safer consumer choices through schools, health centers, and local media.

  4. Green Chemistry Promotion:
    Support industries to adopt PFAS-free manufacturing technologies and promote environmentally friendly substitutes.

  5. Health System Strengthening:
    Integrate environmental exposure screening into asthma clinics and NCD control programs.

  6. Research and Academic Collaboration:
    Encourage universities to conduct exposure assessment and toxicological studies relevant to local contexts, including Lake Victoria and Nairobi industrial areas.

  7. International Partnerships:
    Engage with UNEP, WHO, and the Global Environment Facility (GEF) for funding and technical assistance in PFAS phase-out and remediation.

8. Conclusion

The rising burden of asthma in Africa, compounded by exposure to PFAS and other persistent pollutants, signals an urgent need for integrated environmental and public health responses. PFAS are not only persistent in the ecosystem but also in the body—silently altering immune and respiratory function over time. Kenya and other developing nations stand at a crossroads: they can either continue importing chemical risk or establish bold, science-informed policies to protect future generations. Strengthening PFAS regulation, environmental monitoring, and community education will be critical for achieving chemical safety, clean air, and resilient public health systems under the Sustainable Development Goals (SDGs).

References (Selected)

  • Averina, M. et al. (2021). PFAS exposure and asthma in children: A systematic review. Environmental Research, 196: 110974.

  • DeWitt, J. C. (2022). Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS). Springer.

  • Grandjean, P., & Clapp, R. (2015). Perfluorinated alkyl substances: Emerging insights into health risks. New Solutions, 25(2), 147–163.

  • Liu, X. et al. (2022). Prenatal exposure to PFAS and risk of childhood asthma. Environmental Health Perspectives, 130(4): 47001.

  • UNEP (2023). Global PFAS Assessment: Towards a PFAS-Free Future. United Nations Environment Programme.

  • WHO (2024). Air Pollution and Non-Communicable Diseases: A Global Review.

Comments

Post a Comment

Popular posts from this blog

-
  Impacts of Pit Latrine Waste on Early Puberty in Africa Introduction Across sub-Saharan Africa, pit latrines serve as the primary sanitation infrastructure for over 50% of urban populations and an even higher proportion in rural areas, providing a low-cost solution to the challenge of open defecation. These simple, often unlined pits collect human waste but pose significant risks to environmental and public health due to potential groundwater contamination. Emerging evidence suggests that chemical pollutants from pit latrines, particularly endocrine-disrupting chemicals (EDCs), may contribute to early puberty in children, especially girls, with far-reaching health, social, and educational consequences. Early puberty, defined as pubertal development before age 8 in girls or 9 in boys, is associated with increased risks of mental health disorders, reproductive health issues, and socioeconomic challenges, particularly in resource-constrained settings. In Africa, where sanitation inf...
Read more
-
  Health insurance affordability and the quality of life among low Socioeconomic Status (SES) individuals in Low- and Middle-Income Countries (LMICs)   Preamble: Whereas the right to health is a fundamental human right, it remains inaccessible to many, especially those of low socioeconomic status (SES) in low- and middle-income countries (LMICs); and whereas the affordability of health insurance is a critical factor that can enhance or impede access to necessary healthcare services; we recognize that the ability to obtain health insurance plays a pivotal role in determining the quality of life for individuals and families within these communities. Acknowledging that the lack of affordable health insurance options leads to a disproportionate burden of disease and financial hardship on low SES populations; and understanding that the provision of affordable health insurance is not only a matter of social justice but also an investment in the social and economic development ...
Read more
-
Child Health:  Dealing with Aflatoxins in Children’s Food Aflatoxins, produced primarily by Aspergillus flavus and A. parasiticus , are highly toxic and carcinogenic mycotoxins that contaminate key food crops in tropical and subtropical regions. In low- and middle-income countries (LMICs), especially across sub-Saharan Africa, chronic exposure to aflatoxins in staple foods poses grave health risks for children, including growth impairment, immunosuppression, developmental deficits, and increased vulnerability to infectious diseases. This paper explores the sources of aflatoxin contamination in children's food, its public health impacts, and proposes multisectoral policies and interventions to protect child health and nutrition, with a focus on evidence from Africa. 1. Introduction Aflatoxin contamination is one of the most pressing yet under-addressed food safety challenges affecting children in LMICs. Staple foods such as maize, sorghum, groundnuts, and dairy products are pro...
Read more